BIOMAT Database Logo BIOMAT Database Logo

Therapy for hepatorenal syndrome. 1998

F Wong, and L Blendis

UI MeSH Term Description Entries
D009951 Ornipressin A synthetic analog of vasopressin with ORNITHINE substitution at residue 8 of the cyclic nonapeptide. It is used as a local vasoconstrictor and hemostatic. Ornithine Vasopressin,Orpressin,Vasopressin, Ornithine,Ornithine-8-Vasopressin,POR-8,Ornithine 8 Vasopressin
D006530 Hepatorenal Syndrome Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention. Syndrome, Hepatorenal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000418 Albumins Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating. Albumin

Related Publications

F Wong, and L Blendis
[Therapy for hepatorenal syndrome].
October 2003, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
F Wong, and L Blendis
Vasoconstrictor therapy for the hepatorenal syndrome.
May 2008, Gastroenterology,
F Wong, and L Blendis
[Therapy of hepatorenal syndrome].
January 1997, Praxis,
F Wong, and L Blendis
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.
February 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation,
F Wong, and L Blendis
[Therapy of the hepatorenal syndrome].
May 1987, Minerva medica,
F Wong, and L Blendis
[Therapy of the hepatorenal syndrome].
April 1988, Deutsche medizinische Wochenschrift (1946),
F Wong, and L Blendis
Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosis.
January 2006, Current pharmaceutical design,
F Wong, and L Blendis
[Advances in therapy for ascites and hepatorenal syndrome].
January 2005, Zeitschrift fur Gastroenterologie,
F Wong, and L Blendis
Meta-analysis: terlipressin therapy for the hepatorenal syndrome.
September 2006, Alimentary pharmacology & therapeutics,
F Wong, and L Blendis
[Diagnosis of and multimodality therapy for hepatorenal syndrome].
October 2015, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Copied contents to your clipboard!